DrugPatentWatch Database Preview
« Back to Dashboard
|Title:||Continuous intravenous infusion of adenosine to human patients undergoing percutaneous transluminal angioplasty|
|Abstract:||This invention is concerned with the use of adenosine as an agent for the treatment of human beings. More particularly, this invention is concerned with the administration of adenosine to human patients by continuous intravenous infusion for, inter alia, control of blood pressure, use as a selective vasodilator, decreasing pulmonary vascular resistance, treating acute pulmonary hypertension in conjunction with idiopathic respiratory distress syndrome, in diagnosing pulmonary hypertension in conjunction with cardiac septum defects, in percutaneous transluminal angioplasty (PTCA), in coronary thrombolysis (CTL) and in radionucleide scintography.|
|Inventor(s):||Sollevi; Alf (Bromma, SE)|
|Assignee:||Item Development Aktiebolag (Stocksund, SE)|
|Filing Date:||Dec 15, 1993|
|Claims:||1. In a method for percutaneous transluminal angioplasty (PTCA), for treating coronary artery disease in a human patient comprising inserting a catheter having an inflatable balloon into a coronary artery which has an angiographically demonstrable stenosis, and inflating the balloon, the improvement of administering adenosine to said patient by continuous intravenous infusion to lessen negative effects of said PTCA. |
2. A method as claimed in claim 1 wherein adenosine is infused into a peripheral vein.
3. A method as claimed in claim 1 wherein administration of adenosine is begun shortly before the PTCA procedure and continued during and several hours after said procedure.